An Alzheimer’s treatment from Eli Lilly and Co. failed to slow memory decline in two separate patient studies, but the drug did show some potential to help in mild cases of the mind-robbing condition that is notoriously difficult to treat.
The federal government can’t require tobacco companies to put large graphic health warnings on cigarette packages to show that smoking can disfigure and even kill people.
New research finds that a simple modification may make a cancer drug three times more powerful without the side effects of a higher dose. All it takes is grapefruit juice.
If you are one of the many people who have tried all kinds of creams to get rid of stretch marks with no luck, there’s finally some help.
A new FDA approved treatment called Cellulaze targets cellulite from under the skin. Doctors insert a laser through a small incision. It heats up the tissue that holds fat cells together.
A genetic test maker is asking the FDA to approve its personalized DNA test in a move that, if successful, could boost acceptance of technology that is viewed skeptically by leading scientists who question its usefulness.
The Food and Drug Administration has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS.
Dr. Crystal Foster talks about a dropped plan for doctors to receive pain drug training, a shortage on Excedrin, and a study that says artificial sweeteners can help with weight loss.
The FDA has issued a new report criticizing the company that stored adult stem cells from Governor Rick Perry for use in an experimental procedure for his back pain.
A new combination vaccine that protects infants from two deadly infections that can cause meningitis, meningococcal disease and Hib disease, was approved Thursday by the FDA.
High fructose corn syrup won’t get a wholesome new name after all. The FDA has rejected the Corn Refiners Association’s bid to rename its sweetening agent “corn sugar.”
The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.